ELL 抗体 (AA 531-620)
Quick Overview for ELL 抗体 (AA 531-620) (ABIN1385855)
抗原
See all ELL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 531-620
-
预测反应
- Human,Mouse,Rat,Dog,Cow,Horse
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human ELL
-
亚型
- IgG
-
-
anti-Elongation Factor RNA Polymerase II (ELL) (Internal Region) antibody
ELL 适用: 人, 小鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 551-600) antibodyELL 适用: 人, 小鼠, 犬, 大鼠, Cow, 马, 斑马鱼, 猴 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL 适用: 人, 猴 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) antibodyELL 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 522-619) antibodyELL 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 431-480) antibodyELL 适用: 人, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 350-450) antibodyELL 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (Middle Region) antibodyELL 适用: 人, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL 适用: 人, 小鼠, 犬, 大鼠, Cow, 豚鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (C-Term) antibodyELL 适用: 人, 小鼠, 犬, 大鼠, Cow, 马, 豚鼠, 斑马鱼 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
别名
- ELL
-
背景
-
Synonyms: ELL_HUMAN, Eleven nineteen lysine rich leukemia gene, Eleven-nineteen lysine-rich leukemia protein, ELL1, elongation factor RNA polymerase II, Men, RNA polymerase II elongation factor, RNA polymerase II elongation factor ELL.
Background: Eukaryotic RNA polymerase II mediates the synthesis of mature and functional messenger RNA. This is a multistep process, called the transcription cycle, that includes five stages: preinitiation, promoter, clearance, elongation and termination. Elongation is thought to be a critical stage for the regulation of gene expression. ELL (11-19 lysine-rich leukemia protein), also designated MEN, functions as an RNA polymerase II elongation factor that increases the rate of transcription by suppressing transient pausing by RNA polymerase II. It is also thought to regulate cellular proliferation. ELL is abundantly expressed in peripheral blood leukocytes, skeletal muscle, placenta and testis, with lower expression in spleen, thymus, heart, brain, lung, kidney, liver and ovary. The gene encoding human ELL, which maps to chromosome 19p13.1, is one of several genes that undergo translocation with the MLL gene on chromosome 11q23 in acute myeloid leukemia. MLL (myeloid/lymphoid leukemia, also designated ALL-1 and HRX) regulates embryonal and hematopoietic development.
-
基因ID
- 8178
抗原
-
